Makers of sibutramine hesitating to change insert paper

Published: 2010-03-22 06:59:00

Updated: 2010-03-22 06:59:00

28 producers of sibutramine here are likely to revise the insert paper at the end of this month, during which a possible association between sibutramine (Meridia, Abbott) and an elevated number of cardiac events such as MI, stroke, recurrent cardiac arrest or death that occurred in the Sibutramin...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK